Next week! Hear from Chiadi U. Onyike at AAIC Neuroscience Next, Feb. 23–26. This hybrid event from @alzassociation is happening globally and is a great way to explore the latest in dementia science! Register: https://t.co/tgB0Vqn1F2 #AAICNeuro
I am deeply honoured and truly humbled to receive this congratulatory letter from the #Yobe State Government, #Nigeria issued under the directive of His Excellency, the Executive Governor of the State, on the award of my @wellcometrust Career Development Award.
This recognition not only affirms the importance of our work on #Alzheimer’s disease and #neuroscience in Africa but also highlights the state's commitment to championing innovation and scientific excellence.
I am sincerely grateful to His Excellency, Governor Mai Mala Buni, the Secretary to the State Government, and the people of Yobe for their continued support.
This letter serves as a strong reminder that #science conducted in and for #Africa matters, and that when institutions and governments invest in science, the ripple effect can be transformative.
The Accelerating Drug Discovery for FTD application cycle is open, with LOIs due May 12. The RFP supports lead optimization of novel disease-modifying compounds and in vivo testing of novel lead compounds, biologics, vaccines, or repurposed drug candidates for FTD.
🏆 Awards will provide $300,000-$350,000 based on the stage and scope of research.
👉 Click here to learn more: https://t.co/BbMauKAa6l
Dr. Chiadi Onyike (@conyike), Associate Professor and neuropsychiatrist at The Johns Hopkins University/Hospital, incoming Chair of AFTD’s Medical Advisory Council, and Co-Chair of the #HollowaySummit2025, discusses why we don’t know more about risk factors for FTD.
🔬 Interested in learning more about FTD research? Click here for more info: https://t.co/d1WFtj66Jn
#Dementia cases are on the rise in Northeastern #Nigeria, but there are gaps that need urgent attention. Check out our audit of dementia cases from FNHM Maiduguri – the only neuropsychiatric facility serving over 20M people. https://t.co/QxdpJnWVJj. @RCFNeuro@alzassociation
🧠🚨 New preprint alert!
Check out our dementia audit analysis from Northeastern #Nigeria, which is part of our ongoing efforts to develop a dementia cohort and cellular models in the region to deepen our understanding of #dementia towards therapy
Day 2 of our workshop! Prof. @conyike led training on CDR and innovative tools for dementia diagnosis 🧠💡 It ended with him receiving a customary gift of appreciation from the Federal Neuropsychiatric Hospital Maiduguri.
Another productive meeting in the books with the Northern Nigeria Dementia Group with Prof. @conyike and dedicated clinicians from 5 regional hospitals. Our second session deepened our efforts towards Unified Registry Formation and cohort building for dementia research in the region. A heartfelt thanks to @RCFNeuro for fueling our mission. 🧠🤝 #DementiaNorthernNigeria @BioRTCNig
All preparations now done for the FTD Prevention Initiative (FPI) meeting next week in Paris @LucyL_Russell@A_Bouzigues. We look forward to meeting with genetic FTD cohorts from around the world to meet with pharma and hear about the latest in FTD trials #endftd#ISFTD2022 1/2
@CurePSP@LucBuee@LiGanLab@bess_frost @OskarHansson9 @brucemillerucsf @ytquiroz What a conference! #Tau2022. Brilliant science shared! Bravo! Kudos to everyone involved in putting together an excellent program. It has been a pleasure and honor to work with a terrific group of advocates and scientists.